Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06205342 · ClinicalTrials.gov registry record · Early Phase 1

Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain

A Early Phase 1 study of Chronic Pain and Chronic Pancreatitis, sponsored by Medical University of South Carolina.

Recruiting
Registry status
Early Phase 1
Development phase
48
Enrollment target
1
Study location

NCT06205342 is a Early Phase 1 study of Chronic Pain and Chronic Pancreatitis that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 48 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06205342, a Early Phase 1 study of Chronic Pain and Chronic Pancreatitis, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
Early Phase 1
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

This protocol aims to test whether an infusion of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) can reduce pain associated with chronic pancreatitis (CP) and explore potential mechanisms of MSC action.

Interventions

  • OTHER Other: Placebo
  • DRUG Mesenchymal Stem Cells

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2024-07-17
Est. Completion 2028-06-01
Phase Early Phase 1

What the Registry Record Tells You About NCT06205342

The ClinicalTrials.gov registry entry for NCT06205342 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Other: Placebo is the first listed.

NCT06205342 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT06205342 about?

NCT06205342 is a clinical study titled "Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain". This protocol aims to test whether an infusion of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) can reduce pain associated with chronic pancreatitis (CP) and explore potential mechanisms of MSC action.

What is the current status of trial NCT06205342?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 48 participants. The study started on 2024-07-17. Estimated completion is 2028-06-01.

What conditions does trial NCT06205342 study?

This clinical trial studies the following conditions: Chronic Pain, Chronic Pancreatitis.

What interventions are being tested in trial NCT06205342?

The interventions under investigation include: Other: Placebo (OTHER), Mesenchymal Stem Cells (DRUG).

Who is sponsoring clinical trial NCT06205342?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06205342 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.